botensilimab,balstilimab
agenus
looking forward to there are still avenues for #immunotherapy to be explored in #colorectalcancer #crcsm in terms of agents, as well as differential responses in terms of tumor location/micro-environment. #wcgic2022 chairing. 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22